Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs

Progress in Lipid Research

Volumn 51, Issue 3, 2012, Pages 232-237

  Im, Dong Soon ^a  

^a Pusan National University   (South Korea)

Author keywords

Fish oil; GPCR; GPR120; Omega 3; PPAR ; Resolvin

Indexed keywords

ANTIINFLAMMATORY AGENT; CD59 ANTIGEN; G PROTEIN COUPLED RECEPTOR 120; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESOLVIN; RESOLVIN D1; RESOLVIN E1; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG TARGETING; FATTY ACID METABOLISM; HOMEOSTASIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; FATTY ACIDS, OMEGA-3; HUMANS; RECEPTORS, G-PROTEIN-COUPLED; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84860575447     PISSN: 01637827     EISSN: 18732194     Source Type: Journal    
DOI: 10.1016/j.plipres.2012.02.003     Document Type: Review

References (72)

1. D.Y. Oh, S. Talukdar, E.J. Bae, T. Imamura, H. Morinaga, and W. Fan GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects Cell 142 2010 687 698
2. T. Tanaka, S. Katsuma, T. Adachi, T.A. Koshimizu, A. Hirasawa, and G. Tsujimoto Free fatty acids induce cholecystokinin secretion through GPR120 Naunyn Schmiedebergs Arch Pharmacol 377 2008 523 527
3. C.N. Serhan, S. Krishnamoorthy, A. Recchiuti, and N. Chiang Novel anti-inflammatory-pro-resolving mediators and their receptors Curr topics med chem 11 2011 629 647
4. C.N. Serhan, and N.A. Petasis Resolvins and protectins in inflammation resolution Chem Rev 111 2011 5922 5943
5. V. Wittamer, F. Gregoire, P. Robberecht, G. Vassart, D. Communi, and M. Parmentier The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency J Biol Chem 279 2004 9956 9962
6. 4 that mediates chemotaxis Nature 387 1997 620 624
7. 1 J Exp Med 201 2005 713 722
8. 1 and ChemR23 to regulate inflammation J Immunol 178 2007 3912 3917
9. S. Krishnamoorthy, A. Recchiuti, N. Chiang, S. Yacoubian, C.H. Lee, and R. Yang Resolvin D1 binds human phagocytes with evidence for proresolving receptors Proc Natl Acad Sci USA 107 2010 1660 1665
10. N. Chiang, M. Arita, and C.N. Serhan Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX Prostaglandins Leukot Essent Fatty Acids 73 2005 163 177
11. 4 receptor J Biol Chem 272 1997 6972 6978
12. Y. Le, W. Gong, B. Li, N.M. Dunlop, W. Shen, and S.B. Su Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation J Immunol 163 1999 6777 6784
13. 4 receptor Nat Med 8 2002 1296 1302
14. S. Talukdar, J.M. Olefsky, and O. Osborn Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases Trends Pharmacol Sci 32 2011 543 550
15. J. Dyerberg, H.O. Bang, and N. Hjorne Fatty acid composition of the plasma lipids in Greenland Eskimos Am J Clin Nutr 28 1975 958 966
16. R.T. Holman The slow discovery of the importance of omega 3 essential fatty acids in human health J Nutr 128 1998 427S 433S
17. S.M. Hoy, and G.M. Keating Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia Drugs 69 2009 1077 1105
18. M.H. Davidson, E.A. Stein, H.E. Bays, K.C. Maki, R.T. Doyle, and R.A. Shalwitz Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study Clin Ther 29 2007 1354 1367
19. T.A. Sanders, F.R. Oakley, G.J. Miller, K.A. Mitropoulos, D. Crook, and M.F. Oliver Influence of n-6 versus n-3 polyunsaturated fatty acids in diets low in saturated fatty acids on plasma lipoproteins and hemostatic factors Arterioscler Thromb Vasc Biol 17 1997 3449 3460
20. H.M. Roche, and M.J. Gibney Postprandial triacylglycerolaemia: the effect of low-fat dietary treatment with and without fish oil supplementation Eur J Clin Nutr 50 1996 617 624
21. N.J. Stone Fish consumption, fish oil, lipids, and coronary heart disease Circulation 94 1996 2337 2340
22. H.C. Bucher, P. Hengstler, C. Schindler, and G. Meier N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials Am J Med 112 2002 298 304
23. M.L. Burr, P.M. Sweetham, and A.M. Fehily Diet and reinfarction Eur Heart J 15 1994 1152 1153
24. W.E. Lands Biochemistry and physiology of n-3 fatty acids Faseb J 6 1992 2530 2536
25. J.R. Jones, C. Barrick, K.A. Kim, J. Lindner, B. Blondeau, and Y. Fujimoto Deletion of PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance Proc Natl Acad Sci USA 102 2005 6207 6212
26. L.A. Moraes, L. Piqueras, and D. Bishop-Bailey Peroxisome proliferator-activated receptors and inflammation Pharmacol Ther 110 2006 371 385
27. 2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation Cell 83 1995 813 819
28. G. Krey, O. Braissant, F. L'Horset, E. Kalkhoven, M. Perroud, and M.G. Parker Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay Mol Endocrinol 11 1997 779 791
29. K. Yamamoto, T. Itoh, D. Abe, M. Shimizu, T. Kanda, and T. Koyama Identification of putative metabolites of docosahexaenoic acid as potent PPARγ agonists and antidiabetic agents Bioorg Med Chem Lett 15 2005 517 522
30. V.L. Marcheselli, P.K. Mukherjee, M. Arita, S. Hong, R. Antony, and K. Sheets Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils Prostaglandins Leukot Essent Fatty Acids 82 2010 27 34
31. J.Y. Lee, J. Ye, Z. Gao, H.S. Youn, W.H. Lee, and L. Zhao Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids J Biol Chem 278 2003 37041 37051
32. E. Draper, C.M. Reynolds, M. Canavan, K.H. Mills, C.E. Loscher, and H.M. Roche Omega-3 fatty acids attenuate dendritic cell function via NF-kB independent of PPARγ J Nutr biochem 22 2011 784 790
33. C. Wang, W.S. Harris, M. Chung, A.H. Lichtenstein, E.M. Balk, and B. Kupelnick N-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review Am J Clin Nutr 84 2006 5 17
34. H. Poudyal, S.K. Panchal, V. Diwan, and L. Brown Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action Prog Lipid Res 50 2011 372 387
35. C.N. Serhan Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways Annu Rev Immunol 25 2007 101 137
36. C.N. Serhan, and J. Savill Resolution of inflammation: the beginning programs the end Nat Immunol 6 2005 1191 1197
37. G. Fredman, and C.N. Serhan Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution Biochem J 437 2011 185 197
38. C.N. Serhan, C.B. Clish, J. Brannon, S.P. Colgan, N. Chiang, and K. Gronert Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing J Exp Med 192 2000 1197 1204
39. C.N. Serhan, S. Hong, K. Gronert, S.P. Colgan, P.R. Devchand, and G. Mirick Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals J Exp Med 196 2002 1025 1037
40. C.N. Serhan, R. Yang, K. Martinod, K. Kasuga, P.S. Pillai, and T.F. Porter Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions J Exp Med 206 2009 15 23
41. G. Bannenberg, and C.N. Serhan Specialized pro-resolving lipid mediators in the inflammatory response: an update Biochim Biophys Acta 1801 2010 1260 1273
42. N.G. Bazan The onset of brain injury and neurodegeneration triggers the synthesis of docosanoid neuroprotective signaling Cell Mol Neurobiol 26 2006 901 913
43. J.M. Schwab, N. Chiang, M. Arita, and C.N. Serhan Resolvin E1 and protectin D1 activate inflammation-resolution programmes Nature 447 2007 869 874
44. H. Hasturk, A. Kantarci, T. Ohira, M. Arita, N. Ebrahimi, and N. Chiang RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis Faseb J 20 2006 401 403
45. M. Arita, M. Yoshida, S. Hong, E. Tjonahen, J.N. Glickman, and N.A. Petasis Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis Proc Natl Acad Sci USA 102 2005 7671 7676
46. T. Ishida, M. Yoshida, M. Arita, Y. Nishitani, S. Nishiumi, and A. Masuda Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis Inflamm Bowel Dis 16 2010 87 95
47. Z.Z. Xu, L. Zhang, T. Liu, J.Y. Park, T. Berta, and R. Yang Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions Nat Med 16 2010 592 597
48. M. Uddin, and B.D. Levy Resolvins: natural agonists for resolution of pulmonary inflammation Prog Lipid Res 50 2011 75 88
49. S. Hong, K. Gronert, P.R. Devchand, R.L. Moussignac, and C.N. Serhan Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation J Biol Chem 278 2003 14677 14687
50. Y.P. Sun, S.F. Oh, J. Uddin, R. Yang, K. Gotlinger, and E. Campbell Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation J Biol Chem 282 2007 9323 9334
51. L. Huang, C.F. Wang, C.N. Serhan, and G. Strichartz Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1 Pain 152 2011 557 565
52. C.N. Serhan, N. Chiang, and T.E. Van Dyke Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Nat Rev Immunol 8 2008 349 361
53. B. Gomolka, E. Siegert, K. Blossey, W.H. Schunck, M. Rothe, and K.H. Weylandt Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples Prostaglandins Other Lipid Mediat 94 2011 81 87
54. S.F. Oh, P.S. Pillai, A. Recchiuti, R. Yang, and C.N. Serhan Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation J Clin Invest 121 2011 569 581
55. N. Psychogios, D.D. Hau, J. Peng, A.C. Guo, R. Mandal, and S. Bouatra The human serum metabolome PLoS ONE 6 2011 e16957
56. W.J. Lukiw, J.G. Cui, V.L. Marcheselli, M. Bodker, A. Botkjaer, and K. Gotlinger A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease J Clin Invest 115 2005 2774 2783
57. S.K. Raatz, M.Y. Golovko, S.A. Brose, T.A. Rosenberger, G.S. Burr, and W.R. Wolters Baking reduces prostaglandin, resolvin, and hydroxy-fatty acid content of farm-raised Atlantic salmon (Salmo salar) J Agric Food chem 59 2011 11278 11286
58. 1, and related docosahexaenoic acid-derived products: analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms J Am Soc Mass Spectrom 18 2007 128 144
59. S.F. Oh, T.W. Vickery, and C.N. Serhan Chiral lipidomics of E-series resolvins: aspirin and the biosynthesis of novel mediators Biochim Biophys Acta 1811 2011 737 747
60. A. Ichimura, A. Hirasawa, T. Hara, and G. Tsujimoto Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis Prostaglandins Other Lipid Mediators 89 2009 82 88
61. D.S. Im Discovery of new G protein-coupled receptors for lipid mediators J Lipid Res 45 2004 410 418
62. C.P. Briscoe, M. Tadayyon, J.L. Andrews, W.G. Benson, J.K. Chambers, and M.M. Eilert The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids J Biol Chem 278 2003 11303 11311
63. Y. Itoh, Y. Kawamata, M. Harada, M. Kobayashi, R. Fujii, and S. Fukusumi Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40 Nature 422 2003 173 176
64. A.J. Brown, S.M. Goldsworthy, A.A. Barnes, M.M. Eilert, L. Tcheang, and D. Daniels The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids J Biol Chem 278 2003 11312 11319
65. J. Wang, X. Wu, N. Simonavicius, H. Tian, and L. Ling Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84 J Biol Chem 281 2006 34457 34464
66. A. Hirasawa, K. Tsumaya, T. Awaji, S. Katsuma, T. Adachi, and M. Yamada Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 Nat Med 11 2005 90 94
67. S. Miyauchi, A. Hirasawa, T. Iga, N. Liu, C. Itsubo, and K. Sadakane Distribution and regulation of protein expression of the free fatty acid receptor GPR120 Naunyn-Schmiedebergs Arch Pharmacol 379 2009 427 434
68. S.A. Kliewer, S.S. Sundseth, S.A. Jones, P.J. Brown, G.B. Wisely, and C.S. Koble Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ Proc Natl Acad Sci USA 94 1997 4318 4323
69. H.E. Xu, M.H. Lambert, V.G. Montana, D.J. Parks, S.G. Blanchard, and P.J. Brown Molecular recognition of fatty acids by peroxisome proliferator-activated receptors Mol Cell 3 1999 397 403
70. G. Ferry, V. Bruneau, P. Beauverger, M. Goussard, M. Rodriguez, and V. Lamamy Binding of prostaglandins to human PPARγ: tool assessment and new natural ligands Eur J Pharmacol 417 2001 77 89
71. V. Wittamer, J.D. Franssen, M. Vulcano, J.F. Mirjolet, E. Le Poul, and I. Migeotte Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids J Exp Med 198 2003 977 985
72. I. Migeotte, D. Communi, and M. Parmentier Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses Cytokine Growth Factor Rev 17 2006 501 519